🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, populated with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of entering one group, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these groups, messages show dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious health risks”.